Durata Therapeutics
Clinical, development-stage pharmaceutical company focused on the treatment of infectious diseases.
Date | Investors | Amount | Round |
---|---|---|---|
- | N/A | - | |
N/A | $67.5m | IPO | |
$70.0m | Post IPO Equity | ||
$675m | Acquisition | ||
Total Funding | - |
Date | Investors | Amount | Round |
---|---|---|---|
- | N/A | - | |
N/A | $67.5m | IPO | |
$70.0m | Post IPO Equity | ||
$675m | Acquisition | ||
Total Funding | - |